Healthcare utilization and cost of pneumococcal disease in the United States
Top Cited Papers
Open Access
- 11 March 2011
- Vol. 29 (18) , 3398-3412
- https://doi.org/10.1016/j.vaccine.2011.02.088
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate VaccineThe Journal of Infectious Diseases, 2010
- Superior Immune Response to Protein-Conjugate versus Free Pneumococcal Polysaccharide Vaccine in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimatesThe Lancet, 2009
- Continued Impact of Pneumococcal Conjugate Vaccine on Carriage in Young ChildrenPublished by American Academy of Pediatrics (AAP) ,2009
- Economic Productivity by Age and SexMedical Care, 2009
- Immunological responses to pneumococcal vaccine in frail older peopleVaccine, 2008
- Population Snapshot of EmergentStreptococcus pneumoniaeSerotype 19A in the United States, 2005The Journal of Infectious Diseases, 2008
- Adults with Invasive Pneumococcal Disease: Missed Opportunities for VaccinationAmerican Journal of Preventive Medicine, 2006
- Preventability of Invasive Pneumococcal Disease and Assessment of Current Polysaccharide Vaccine Recommendations for Adults: United States, 2001–2003Clinical Infectious Diseases, 2006
- Bacteriological findings in nasopharynx specimens from patients with a clinical diagnosis of acute sinusitisScandinavian Journal of Primary Health Care, 2001